Características clínicas e funcionais de pacientes em avaliação para transplante de pulmão do Hospital Israelita Albert Einstein (HIAE)
Clinical and functional characteristics of patients undergoing evaluation for lung transplantation at the Hospital Israelita Albert Einstein (HIAE)
Silvia Ferreira Maciel, Juliana de Cássia Moura Oliveira, Melline Della Torre de Almeida, José Eduardo Afonso Junior
Resumo
Introdução: A sobrevida, após o transplante pulmonar, depende de variáveis prognósticas dos candidatos em lista, tais como: idade, diagnóstico e capacidade de exercício. Objetivo: Caracterizar a população de pacientes em avaliação para inclusão em lista para transplante de pulmão assistidos pela equipe de fisioterapia do Hospital Israelita Albert Einstein (HIAE). Métodos: Estudo clínico, unicêntrico, coorte retrospectivo. Foram avaliados, 98 pacientes pela equipe de fisioterapia, para possível inclusão em lista de transplante pulmonar do HIAE, entre fevereiro de 2007 a maio de 2012. Os pacientes foram classificados quanto ao tipo de doença: doenças obstrutivas, doenças restritivas, doenças supurativas e outras. Foram incluídos, todos os indivíduos submetidos a uma avaliação respiratória fisioterapêutica completa e que realizaram o teste de caminhada de seis minutos (TC6). Resultados: Os pacientes demonstraram características similares, tais como histórico de tabagismo, dependência de oxigênio e sedentarismo. Os pacientes obstrutivos apresentaram volume expiratório forçado no primeiro segundo (VEF1 )de 0,85 ± 0,45 L (27,40±14,85 %) e os restritivos, capacidade vital forçada (CVF) de 1,54 ± 0,59 L (43,59±14,82%). Com relação à capacidade funcional, o grupo das doenças supurativas era mais jovem e obteve melhor desempenho no TC6: 343±129m (55,51±19,91%) vs 279±114m (48,51±19,08%) vs 266±122m (46,06±22,78), quando comparados com os grupos de doenças obstrutivas e restritivas, respectivamente. Conclusão: Na nossa população, candidatos a transplante de pulmão, apesar de cursarem com histórico progressivo de sintomas de forma similar e limitação na capacidade funcional, apresentam características clínicas e/ou antropométricas distintas. Sendo assim, possivelmente, podem apresentar prejuízos na qualidade de vida, por implicações não somente respiratórias, mas, também, musculoesqueléticas e, consequentemente, sociais.
Palavras-chave
Abstract
Introduction: The time of life after the transplantation depends on variables of the candidates in waiting lists such as age, diagnosis and exercise tolerance. Objective: To characterize the patient population evaluated for inclusion in the list for lung transplantation who were assisted by the physiotherapy team at Hospital Israelita Albert Einstein (HIAE), as well as their clinical and functional characteristics. Methods: Clinical study, singlecenter, retrospective cohort. We evaluated 98 patients by the physiotherapy team for possible inclusion in the lung transplant list of HIAE between February 2007 and May 2012. The patients were classified according to type of diseases: obstructive disease, restrictive diseases, suppurative diseases and others. We included all patients undergoing a complete respiratory evaluation of physical therapy and the Six Minute Walk Test (6MWT). Results: Patients showed similar characteristics such as history of smoking, oxygen dependency and inactivity. Patients with obstructive diseases presented the forced expiratory volume in the first second (FEV1) of 0.85 ± 0.45 L (27.40±14.85 %) and restrictive diseases, forced vital capacity (FVC) of 1.54 ± 0.59 L (43.59±14.82 %). Regarding functional capacity, the suppurative group was younger and presented a better performance on the 6MWT: 343±129m (55.51±19.91 %), compared to the obstructive and restrictive diseases 279±114m (48.51±19.08 %) vs 266±122m (46.06±22.78 %) respectively. Conclusion: In our population, candidates for lung transplantation, have similar symptoms and limitations in functional capacity, with distinct clinical and / or anthropometric characteristics. Thus, they may present impairments in quality of life, not only caused by respiratory disorders, but also caused by musculoskeletal and therefore social implications.
Keywords
References
1. Langer D, Cebrià I, Iranzo MA, Burtin C,Verleden SE, Vanaudenaerde BM, Trooster T, et al. Determinants of physical activity in daily life in candidates for lung transplantation. Respir Med. 2012 May;106(5):747-54.
2. Lahzami S, Bridevaux PO, Soccal PM, Wellinger J, Robert JH, Ris HB, Aubert JD. Survival impact of lung transplantation for COPD. Eur Respir J. 2009 Jul;36(1):74-80.
3. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J.Respir Crit Care Med. 2007 Sep 15;176(6):532-55.
4. Wijkstra PJ, Vergert Ten EM, Mark van der Th W, Postma DS, Altena Van R, Kraan J, Koëter GH. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax. 1994 May;49(5):468-72.
5. Downs AM. Physical therapy in lung transplantation. Phys Ther. 1996 Jun;76(6):626-42.
6. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med. 2011 Jul 15;184(2):159-71.
7. D’Império F. Critérios de indicação e de seleção dos candidatos para transplante de pulmão. Pulmão RJ. 2006;15(3):175-83.
8. Janete FB, Fernandes PMP, Medeiros IL. Transplante pulmonar. Rev Med (São Paulo). 2009 JulSet;88(3):111-22.
9. Lahzami S, Aubert JD. Lung transplantation for COPD-evidence-based? Swiss Med Wkly. 2009 Jan 10;139(1-2):4-8.
10. Dudley KA, El-Chemaly S. Cardiopulmonary exercise testing in lung transplantation: a review. Pulm Med. 2012;2012: 237852.
11. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, et al. Prognostic value of desaturation during a 6-minutes walk test in idiopathic intersticial pneumonia. Am J Respir Crit Care Med. 2003 Nov 1;168(9):1084-90.
12. Lederer DJ, Arcasoy SM, Wilt JS, Ovidio FD, Sonett JR, Kawut SM. Six-minute-walk distance jpredicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006 Sep 15;174(6):659-64.
13. Shorr AF, Davies DB, Nathan SD. Outcomes for patients with sarcoidosis awaiting lung transplantation. Chest. 2002 Jul;122(1):233-8.
14. Rand S, Prasad SA. Exercise as part of a cystic fibrosis therapeutic routine. Expert Rev Respir Med. 2012 Jun;6(3):341-52.
15. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006 Oct 3;114(14):1482-9.
16. Castro AG, Cañas BS, Suescun AQ, Peña MSH, Fernández CG, Llorca YJ. Valoración de la capacidad preoperatoria al ejercicio como factor predictivo de supervivencia en enfermos sometidos a trasplante pulmonar. Med Intensiva. 2008 Mar;32(2):65-70.
17. Blanhir JEM, Vidal CDP, Romero MJRR, Castro MMGC, Villegas AL, Zamboni M. Teste de caminhada de seis minutos: uma ferramenta valiosa na avaliação do comprometimento pulmonar. J Bras Pneumol. 2011 Jan-Fev;37(1):110-7.
18. Soares MR, Pereira CAC. Teste de caminhada de seis minutos: valores de referência para adultos saudáveis no Brasil. J Bras Pneumol. 2011 Set-Out;37(5):576-83.
19. Maury G, Langer D, Verleden G, Dupont L, Gosselink R, Decramer M, Trooster T. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant. 2008 Jun;8(6):1275-81.
20. Kotsimbos T, Williams TJ, Anderson GP. Update on lung transplantation: programmes, patients and prospects. Eur Respir Rev. 2012 Dec 1;21(126):271-305.
21. Stevens D, Elpern E, Sharma K, Szidon P, Ankin M Kesten S. Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1540-3.
22. Hernandes NA, Teixeira DC, Probst VS, Brunetto AF, Ramos EMC, Pitta F. Perfil do nível de atividade física na via diária de pacientes portadores de DPOC no Brasil. J Bras Pneumol. 2009 Oct;35(10):949-56.
23. King TE, Toose JA, Schwarz MI, Brown KR, Cherniack RM. Predicting Survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2011 Oct 1;164(7):1171-81.
24. Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S. Walking distance on 6MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med. 2009 Jan;103(1):117-23.
25. Delgano B, Sitbon O, Savale L, Garcia G, O’Callaghan DS, Jaïs X, et al. Characterization of pulmonary arterial hypertension patients walking more than 450m in 6 min at diagnosis. Chest. 2010 Jun;137(6):1297-303.
26. Yankaskas JR, Mallory GB Jr. Lung transplantation in cystic fibrosis: concensus conference statement. Chest. 1998 Jan;113(1):217-26.
27. Samano MN. Transplante pulmonar em pacientes portadores de bronquiectasias: experiência do InCor/HCFMUSP [Internet]. São Paulo: FAPESP; 2012-2013 [citado 2012 Set 30]. Disponível em: http://www.bv.fapesp.br/pt/bolsas/136382/transplante-pulmonar-pacientes-portadores-bronquiectasias -experiencia-do-incorhcfmusp/.
28. Martinu T, Babyak MA, Connell CFO, Carney RM, Trulock EP, Davis RD, et al. Baseline 6-min walk distance predicts survival in lung transplant candidates. Am J Transplant. 2008 Jul;8(7):1498- 505.
29. Tuppin MP, Paratz JD, Chang AT, Seale HE, Walsh JR, Kermeeen FD, et al. Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation. J Heart Lung Transplant. 2008 Jul;27(7):729-34.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email